US moves to sell gene-edited mushrooms fuel doubts over British ban on GM imports
By Robin McKie,
The Guardian
| 04. 23. 2016
Untitled Document
American regulators have allowed the cultivation and sale of two crops modified with the gene-editing technique known as Crispr. The crops – a white button mushroom and a form of corn – are the first Crispr plants to be permitted for commercial use in the US.
The move is a boost for new technology in the creation of foodstuffs, but is expected to worsen the considerable confusion in Britain over the use of gene-editing in agriculture and the importing of crops created using such technology.
A committee of European commission regulators was expected to report last month on whether gene-edited crops should be classed as genetically-modified organisms or should be freed from the severe restrictions concerning GMOs in Europe. At the last minute it announced a delay in its verdict – to the dismay of many UK scientists.
“The committee knew it would be highly controversial, no matter what decision it made, so they have kicked the issue into the long grass, and that is very damaging,” said crop scientist Professor Huw Jones of Aberystwyth university.
“Researchers...
Related Articles
By Pete Shanks
| 02.27.2026
Last month, we published “The Shameful Legacy of Tuskegee” which focused on a proposed experiment in Guinea-Bissau. The study’s plan echoed the notorious Tuskegee disaster, withholding safe, effective vaccines against hepatitis B from some newborns while inoculating others. It was to be financed by the U.S. but performed by a controversial Danish team. That project provoked a multi-national outcry, leading to a remarkable response from the World Health Organization:
WHO has significant concerns regarding the study’s scientific...
By Jenn White, NPR | 02.26.2026
By Kiana Jackson and Shannon Stubblefield, New Disabled South | 02.09.2026
"MC0_8230" via Wikimedia Commons licensed under CC by 2.0
This report documents a deliberate assault on disabled people in the United States. Not an accident. Not a series of bureaucratic missteps. An assault that has been coordinated across agencies...
By Scott Solomon, The MIT Press Reader | 02.12.2026
Chris Mason is a man in a hurry.
“Sometimes walking from the subway to the lab takes too long, so I’ll start running,” he told me over breakfast at a bistro near his home in Brooklyn on a crisp...